These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28520967)

  • 1. In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies.
    Nixon CC; Mavigner M; Silvestri G; Garcia JV
    J Infect Dis; 2017 Mar; 215(suppl_3):S142-S151. PubMed ID: 28520967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models.
    Bricker KM; Chahroudi A; Mavigner M
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents.
    Margolis DM; Archin NM
    J Infect Dis; 2017 Mar; 215(suppl_3):S111-S118. PubMed ID: 28520964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latency reversal and viral clearance to cure HIV-1.
    Margolis DM; Garcia JV; Hazuda DJ; Haynes BF
    Science; 2016 Jul; 353(6297):aaf6517. PubMed ID: 27463679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies.
    Henrich TJ; Deeks SG; Pillai SK
    J Infect Dis; 2017 Mar; 215(suppl_3):S134-S141. PubMed ID: 28520968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of HIV latency in humanized BLT mice.
    Denton PW; Olesen R; Choudhary SK; Archin NM; Wahl A; Swanson MD; Chateau M; Nochi T; Krisko JF; Spagnuolo RA; Margolis DM; Garcia JV
    J Virol; 2012 Jan; 86(1):630-4. PubMed ID: 22013053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research.
    Bauer AM; Ziani W; Lindemuth E; Kuri-Cervantes L; Li H; Lee FH; Watkins M; Ding W; Xu H; Veazey R; Bar KJ
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models to achieve an HIV cure.
    Kumar N; Chahroudi A; Silvestri G
    Curr Opin HIV AIDS; 2016 Jul; 11(4):432-41. PubMed ID: 27152962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on Human Immunodeficiency Virus (HIV) Cure: HIV Persistence in Tissue.
    Boritz EA; Douek DC
    J Infect Dis; 2017 Mar; 215(suppl_3):S128-S133. PubMed ID: 28520970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
    Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
    Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
    Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.
    Del Prete GQ; Lifson JD
    Curr Top Microbiol Immunol; 2018; 417():69-109. PubMed ID: 29026923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of finding a cure for HIV infection.
    Richman DD; Margolis DM; Delaney M; Greene WC; Hazuda D; Pomerantz RJ
    Science; 2009 Mar; 323(5919):1304-7. PubMed ID: 19265012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
    Chun TW; Justement JS; Moir S; Hallahan CW; Maenza J; Mullins JI; Collier AC; Corey L; Fauci AS
    J Infect Dis; 2007 Jun; 195(12):1762-4. PubMed ID: 17492591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.
    Battistini A; Sgarbanti M
    Viruses; 2014 Apr; 6(4):1715-58. PubMed ID: 24736215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV latency in the humanized BLT mouse.
    Marsden MD; Kovochich M; Suree N; Shimizu S; Mehta R; Cortado R; Bristol G; An DS; Zack JA
    J Virol; 2012 Jan; 86(1):339-47. PubMed ID: 22072769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
    Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
    Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV cure: knocking on the door.
    Durand CM; Flexner C
    Clin Pharmacol Ther; 2013 May; 93(5):382-4. PubMed ID: 23598454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain.
    Asahchop EL; Meziane O; Mamik MK; Chan WF; Branton WG; Resch L; Gill MJ; Haddad E; Guimond JV; Wainberg MA; Baker GB; Cohen EA; Power C
    Retrovirology; 2017 Oct; 14(1):47. PubMed ID: 29037245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of HIV-1 persistence and evolving strategies for virus eradication.
    Dhamija N; Rawat P; Mitra D
    Subcell Biochem; 2013; 61():479-505. PubMed ID: 23150264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.